[Federal Register: July 29, 2008 (Volume 73, Number 146)]
[Notices]
[Page 43943-43944]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr29jy08-66]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
Periodically, the Health Resources and Services Administration
(HRSA) publishes abstracts of information collection requests under
review by the Office of Management and Budget (OMB), in compliance with
the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35). To request
a copy of the clearance requests submitted to OMB for review, e-mail
paperwork@hrsa.gov or call the HRSA Reports Clearance Office on (301)
443-1129.
The following request has been submitted to the Office of
Management and Budget for review under the Paperwork Reduction Act of
1995:
Proposed Project: Sickle Cell Disease Treatment Demonstration Program
(SCDTDP), Health Resources and Services Administration (HRSA): NEW
In 2004 Congress enacted and the President signed into law Public
Law 108-357, the American Jobs Creation Act of 2004. Section 712 of
Public Law 108-357 authorized a demonstration program for the
prevention and treatment of Sickle Cell Disease. The legislation was
enacted to (1) create an optional medical assistance program for
individuals with Sickle Cell Diseases for treatment and education,
genetic counseling and other services to prevent mortality and decrease
morbidity from Sickle Cell Disease, and (2) create a demonstration
program, the SCDTDP, under HRSA. The SCDTDP provides grants to
federally-qualified and nonprofit health care providers to establish
geographically distributed regional networks that will work with
comprehensive Sickle Cell Disease centers and community-based support
organizations to provide coordinated, comprehensive, culturally
competent, and family-centered care to families with Sickle Cell
Disease. In fiscal year 2006, HRSA awarded four, 4-year grants to the
Illinois Sickle Cell Association Network, Alabama Network for Sickle
Cell Care, Access, Prevention, and Education, Carolina Partnership for
Sickle Cell Treatment Continuum of Care, and the Cincinnati Sickle Cell
Network.
Under the authorizing legislation, a National Coordinating Center
(NCC) was established to (1) collect, coordinate, monitor, and
distribute data, best practices and findings regarding the activities
of the demonstration program, (2) identify a model protocol for
eligible entities with respect to the prevention and treatment of
Sickle Cell Disease, (3) identify educational materials regarding the
prevention and treatment of Sickle Cell Disease, and (4) prepare a
final report on the efficacy of the demonstration program based on
evaluation findings.
As part of the evaluation, pre and post utilization and
satisfaction data and quality of life assessments will be collected
from the demonstration clients during various phases of their
participation. These data will be collected through medical record
abstractions and self-report using hard copy questionnaires and
submitted to the NCC for processing and analysis.
The total burden estimate per participant is shown below:
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Responses per Total Hours per Total burden
Type of respondent Form name respondents respondent responses response hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Sickle Cell Disease clients or caregivers. Utilization Questionnaire 400 1 400 .75 300
(pre-demonstration).
Sickle Cell Disease clients or caregivers. Utilization Questionnaire 400 1 400 .50 200
(post demonstration).
Sickle Cell Disease clients or caregivers. SF-36 Health Survey for 280 2 560 .25 140
adults over 18 years of age.
Parents of Sickle Cell Disease clients.... PedsQL for parents.......... 120 2 240 .25 60
Sickle Cell Disease clients age 18 and PedsQL for children and 100 2 200 .25 50
younger. adolescents.
Sickle Cell Disease clients or caregivers. The Medical Home Family 400 2 800 .25 200
Index (Health Care
Satisfaction).
-------------------------------------------------------------------------------
Total................................. ............................ 500 .............. 2,600 .............. 950
--------------------------------------------------------------------------------------------------------------------------------------------------------
Written comments and recommendations concerning the proposed
information collection should be sent within 30 days of this notice to
the desk officer for HRSA, either by e-mail to OIRA_
submission@omb.eop.gov or by fax to 202-395-6974. Please direct all
correspondence to the ``attention of the desk officer for HRSA.''
[[Page 43944]]
Dated: July 23, 2008.
Alexandra Huttinger,
Director, Division of Policy Review and Coordination.
[FR Doc. E8-17354 Filed 7-28-08; 8:45 am]
BILLING CODE 4165-15-P